GSK`s Blenrep bags approval in China
20 Apr 2026 //
PRESS RELEASE
GSK`s Blenrep Gets All-Clear In NICE Guidance
16 Apr 2026 //
FIERCE PHARMA
GSK Initiates 5 Phase 3 Trials For Hansoh`s Gynecological Cancer
13 Apr 2026 //
ENDPOINTS
GSK Eyes Blockbuster Potential In Targeted Cancer Therapy
12 Apr 2026 //
REUTERS
GSK`s Exdensur approved for new use in China
08 Apr 2026 //
PRESS RELEASE
GSK`s Exdensur wins asthma nod in China
30 Mar 2026 //
FIERCE PHARMA
Myriad Genetics Gets FDA Nod For Mychoice CDx Test With Zejula
17 Mar 2026 //
GLOBENEWSWIRE
GSK gets US FDA approval for expanded use of RSV vaccine
14 Mar 2026 //
REUTERS
BioVersys Doses First Patient in Phase 2b AlpE Pulmonary TB Trial
13 Mar 2026 //
GLOBENEWSWIRE
New Proteomics Data Offering Joins Genomic Discovery Alliance
05 Mar 2026 //
PR NEWSWIRE
GSK Props Up Its Cabenuva In Adolescents With Long-Term Data
26 Feb 2026 //
FIERCE PHARMA
GSK Acquires 35Pharma to Advance HS235 for Pulmonary Hypertension
25 Feb 2026 //
GLOBENEWSWIRE
Frontier Biotech, GSK Seal Global siRNA Pact
25 Feb 2026 //
PR NEWSWIRE
GSK AREXVY Linked to Lower RSV-Related Risks
18 Feb 2026 //
BUSINESSWIRE
Viiv Pharma Unveils Long-Acting HIV Breakthroughs At CROI 2026
17 Feb 2026 //
BUSINESSWIRE
GSK`s Arexvy RSV Vaccine Under Regulatory Review In China
10 Feb 2026 //
PHARMIWEB
GSK Prioritizes `Downstream Effects` Of Obesity Over GLP-1s
04 Feb 2026 //
BIOSPACE
Wave Life Sciences Expedites WVE-006 Regulatory Process
02 Feb 2026 //
GLOBENEWSWIRE
GSK’s Arexvy, receives European approval for expanded use
26 Jan 2026 //
PRESS RELEASE
Alteogen Secures Exclusive License For Subcutaneous Dostarlimab
21 Jan 2026 //
PR NEWSWIRE
GSK to buy RAPT Therapeutics in $2.2 Billion Deal
19 Jan 2026 //
REUTERS
GSK Inks Model Deal In $50M Bet On Noetik`s Cancer AI Platform
08 Jan 2026 //
BUSINESSWIRE
GSK & Ionis`s `Functional Cure` For Hep B Proves Worth In Ph. 3
07 Jan 2026 //
BUSINESSWIRE
GSK`s Exdensur Gains Approval In Japan
06 Jan 2026 //
PRESS RELEASE
GSK`s Nucala Picks Up COPD Nod In China
05 Jan 2026 //
PRESS RELEASE
LIXTE And Collaborators Expand Clear Cell Ovarian Cancer Trial
23 Dec 2025 //
GLOBENEWSWIRE
GSK Resubmits Tebipenem HBr NDA To FDA For Complicated UTIs
19 Dec 2025 //
GLOBENEWSWIRE
CAMP4 & GSK Partner To Advance RNA-Based Therapeutics
18 Dec 2025 //
GLOBENEWSWIRE
GSK`s Saphnelo EU Approved For Self-Administered Lupus Pen
16 Dec 2025 //
PHARMIWEB
GSK`s Long-Acting Asthma Med Wins CHMP Backing
12 Dec 2025 //
FIERCE PHARMA
Oxford Biotherapeutics Collaborates With GSK On Cancer Antibody
10 Dec 2025 //
PHARMIWEB
GSK, Anaptysbio sue each other over Jemperli revenue
22 Nov 2025 //
BIOPHARMADIVE
GSK Fleming Initiative Launch New Fight Against Antimicrobial
21 Nov 2025 //
INDPHARMAPOST
GSK Partners LTZ Therapeutics For Advanced Cancer Treatments
21 Nov 2025 //
INDPHARMAPOST
GSK Picks 1st Biotech Partners Under $7 B Flagship Pact
20 Nov 2025 //
FIERCE BIOTECH
Scynexis Transfers Brexafemme NDA to Gsk
19 Nov 2025 //
GLOBENEWSWIRE
GSK & AN2 Partner on Boron-Based LeuRS Inhibitors for TB
10 Nov 2025 //
BUSINESS WIRE
GSK Loses Hope For CD226 Cancer Therapies, Dropping Ph. 2 Assets
29 Oct 2025 //
FIERCE BIOTECH
GSK Pens $750M Deal For COPD-Focused Oligonucleotide In Phase 1
28 Oct 2025 //
FIERCE BIOTECH
Biogen Seeks To Stand Out In Lupus With New Anti-CD40L Data
28 Oct 2025 //
BIOSPACE
GSK Acquires Prostate-Cancer Candidate From Syndivia For £268M
27 Oct 2025 //
FIERCE BIOTECH
US FDA Approves Gsk`s Blood Cancer Treatment
25 Oct 2025 //
REUTERS
Ph3 PIVOT-PO Data Show Tebipenem HBr as First Oral Carbapenem
21 Oct 2025 //
GLOBENEWSWIRE
GSK`s Shingrix Prefilled Syringe Gets Positive CHMP Opinion
21 Oct 2025 //
PHARMIWEB
GSK Says `s Tuned` For More ADC Data As Hansoh Posts 49% ORR
19 Oct 2025 //
FIERCE BIOTECH
GSK Tout Study Showing Tolerability Edge for Its Long-Acting PrEP
15 Oct 2025 //
FIERCE PHARMA
GSK`s Shingrix Approved In China For Shingles Prevention
14 Oct 2025 //
PHARMIWEB
Clover Reveals Encouraging Phase I Results For RSV Vaccines
14 Oct 2025 //
PR NEWSWIRE
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo
13 Oct 2025 //
PR NEWSWIRE
GSK Overturns Pmcpa`s Most Serious Sanction In COVID Release Row
03 Oct 2025 //
FIERCE PHARMA
GSK Adds Moderna`s Next-Gen Covid Shot to MRNA Patent Lawsuit
05 Sep 2025 //
FIERCE PHARMA
GSK forays into oncology in India with Jemperli and Zejula
25 Aug 2025 //
INDPHARMAPOST
GSK anti-TIM-3 antibody flunks ph. 3, as TIGIT fail costs $629M
31 Jul 2025 //
FIERCE BIOTECH
GSK`s Blood Cancer Drug gets EU Approval
26 Jul 2025 //
REUTERS
FDA Delays Decision on GSK`s Blenrep Comeback by 3 Months
24 Jul 2025 //
FIERCE PHARMA
FDA Approves Pre-filled Version of GSK`s Shingles Vaccine
18 Jul 2025 //
PRESS RELEASE
GSK Plans `very Limited` Job Cuts for Global R&D Team
15 Jul 2025 //
FIERCE BIOTECH
GSK Ships Influenza Vaccine Doses for 2025-26 Flu Season
10 Jul 2025 //
BUSINESSWIRE
Bharat, GSK to halve price of malaria vaccine by 2028
26 Jun 2025 //
FIERCE PHARMA
FDA Approved Benlysta Autoinjector for Kids with Lupus Nephritis
24 Jun 2025 //
BUSINESSWIRE

Market Place
Sourcing Support